Latest On Regulus Therapeutics Inc (RGLS):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-12 00:11 EST | News | Regulus Therapeutics GAAP EPS of -$0.42 beats by $0.02 | N/A |  |
| 2023-04-13 10:07 EST | News | Regulus Therapeutics up 19% on raising $15M | N/A | |
| 2023-03-23 23:58 EST | News | Regulus Therapeutics GAAP EPS of -$0.40 beats by $0.11 | N/A | |
| 2022-11-12 10:34 EST | News | Regulus Therapeutics Inc. (RGLS) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-10 22:36 EST | News | Regulus Therapeutics GAAP EPS of -$0.50 | N/A | |
| 2022-11-10 22:35 EST | News | Regulus Therapeutics, Inc. (RGLS) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-10 05:12 EST | News | Regulus Therapeutics Q3 2022 Earnings Preview | N/A | |
| 2022-09-12 23:21 EST | News | Regulus surges 15% after Phase 1 data for kidney disease candidate | N/A | |
| 2022-09-09 10:03 EST | News | Regulus Therapeutics Inc. 2022 Q2 - Results - Earnings Call Presentation | N/A | |
| 2022-08-12 07:19 EST | News | Regulus Therapeutics GAAP loss per share narrows | N/A | |
| 2022-08-12 07:18 EST | News | Regulus Therapeutics, Inc. (RGLS) CEO Joseph Hagan on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-10 22:49 EST | News | Regulus Therapeutics Q2 2022 Earnings Preview | N/A | |
| 2022-05-13 00:13 EST | News | Regulus Therapeutics GAAP EPS of -$0.05 | N/A | |
| 2022-05-13 00:13 EST | News | Regulus Therapeutics, Inc. (RGLS) CEO Joseph Hagan on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-12 04:13 EST | News | Regulus spikes as FDA clears trial for kidney disease candidate | N/A | |
| 2022-03-11 17:10 EST | News | Regulus Therapeutics Inc. (RGLS) CEO Jay Hagan on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-10 21:14 EST | News | Regulus Therapeutics GAAP EPS of -$0.07 | N/A | |
| 2022-03-10 04:42 EST | News | Regulus Therapeutics Q4 2021 Earnings Preview | N/A | |
| 2021-11-25 03:29 EST | News | Regulus to receive $34.6M through private placement of equity | N/A | |
| 2021-11-11 12:19 EST | News | Regulus Therapeutics EPS misses by $0.02, revenue in-line | N/A | |
| 2021-11-11 12:19 EST | News | Regulus Therapeutics Inc. (RGLS) CEO Jay Hagan on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-10 15:02 EST | News | Regulus Therapeutics Q3 2021 Earnings Preview | N/A | |
| 2021-11-03 18:11 EST | News | Warning: RGLS is at high risk of performing badly | N/A | |
| 2021-10-13 07:14 EST | News | Regulus falls 22% on decision to focus on another kidney disease candidate (update) | N/A | |
| 2021-09-03 01:36 EST | News | Cantor initiates Regulus as overweight on microRNA technology platform; sees 147% upside | N/A | |
| 2021-08-13 20:03 EST | News | Regulus Therapeutics (RGLS) Investor Presentation - Slideshow | N/A | |
| 2021-08-11 07:19 EST | News | Regulus Therapeutics EPS in-line | N/A | |
| 2021-08-11 07:19 EST | News | Regulus Therapeutics' (RGLS) CEO Jay Hagan on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-02 22:55 EST | News | The Read On Regulus Therapeutics | N/A | |
| 2021-07-21 22:10 EST | News | Regulus Therapeutics reports additional RGLS4326 data in polycystic kidney disease | N/A | |
| 2021-05-04 05:06 EST | News | Regulus reports top-line data from early-stage RGLS4326 trial in polycystic kidney disease | N/A | |
| 2021-04-16 01:15 EST | News | Regulus Therapeutics completes dosing in early-stage kidney disease trial | N/A | |
| 2021-03-11 00:40 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-10 12:13 EST | Earnings Estimate | An EPS average of -$0.43 is estimated for the 2022 year. | Sell | |
| 2021-03-10 12:13 EST | Earnings Estimate | An EPS average of -$0.14 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-03-09 22:51 EST | News | Regulus Therapeutics EPS of -$0.03 | N/A | |
| 2021-02-18 12:15 EST | Analyst Rating | The Analyst Target Price has increased from $1 to $1.33. | Neutral | |
| 2021-02-10 17:43 EST | News | Regulus Therapeutics gains on completion of enrollment in study of RGLS4326 for kidney disease | N/A | |
| 2020-12-08 11:12 EST | News | Regulus Therapeutics announces closing of $19.4M private placement | N/A | |
| 2020-11-26 21:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-10 04:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-09 05:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-09 05:02 EST | Earnings Estimate | An EPS average of -$0.17 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-11-08 00:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 16:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 15:48 EST | News | Regulus Therapeutics EPS beats by $0.17, beats on revenue | N/A | |
| 2020-11-03 08:35 EST | News | Regulus Therapeutics +23% after achieving milestone under Sanofi deal | N/A | |
| 2020-10-16 01:34 EST | News | Dosing underway in Regulus Therapeutics' RGLS4326 study for kidney disease | N/A | |
| 2020-10-13 18:17 EST | News | Regulus announces receipt of milestone payment from Sanofi | N/A | |
| 2020-09-26 13:53 EST | Financials | Company financials have been released. | Neutral | |
About Regulus Therapeutics Inc (RGLS):
Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that target microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS4326, an anti-miR targeting miR-17, which is in Phase 1 development for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products, which include RGLS5579 glioblastoma multiforme program; and Hepatitis B virus, non-alcoholic steatohepatitis, and cell therapies programs. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.
General
- Name Regulus Therapeutics Inc
- Symbol RGLS
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 24
- Last Split Factor1:12
- Last Split Date2018-10-04
- Fiscal Year EndDecember
- IPO Date2012-10-04
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.regulusrx.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 7.71
- Price/Book (Most Recent Quarter) 11.82
- Enterprise Value Revenue 8.74
- Enterprise Value EBITDA 1.55
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.35
- Next Year EPS Estimate -$0.37
- Next Quarter EPS Estimate -$0.14
- Profit Margin -157%
- Operating Margin -141%
- Return on Assets -22%
- Return on Equity -68%
- Revenue 10.01 million
- Earnings Per Share -$2.43
- Revenue Per Share $0.29
- Gross Profit -5341000
- Quarterly Earnings Growth 27677.8%
View More
Highlights
- Market Capitalization 134.13 million
- EBITDA -23412000
- PEG Ratio -0.04
- Analyst Target Price $1.33
- Book Value Per Share $0.39
View More
Share Statistics
- Shares Outstanding 72.5 million
- Shares Float 58.68 million
- % Held by Insiders 643%
- % Held by Institutions 31%
- Shares Short 3.14 million
- Shares Short Prior Month 2.76 million
- Short Ratio 1.15
- Short % of Float 5%
- Short % of Shares Outstanding 5%
View More
Technicals
- Beta 2.31
- 52 Week High $1.97
- 52 Week Low $0.42
- 50 Day Moving Average 1.53
- 200 Day Moving Average 0.96
View More
Dividends
- Dividend Date 2018-10-04
- ExDividend Date N/A
- Dividend Yield 0%
View More
Regulus Therapeutics Inc (RGLS) Dividend Calendar:
RGLS's last dividend payment was made to shareholders on October 4, 2018.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Regulus Therapeutics Inc (RGLS) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-09 | $5 million | -$0.03 | -$0.14 | 78.57% |
| 2020-09-30 | 2020-11-05 | $N/A | -$0.04 | -$0.20 | 80.32% |
| 2020-06-30 | 2020-08-13 | $N/A | -$0.23 | -$0.20 | -16.93% |
| 2020-03-31 | 2020-05-14 | $6000 | -$0.25 | -$0.12 | -108.33% |
| 2019-12-31 | 2020-03-12 | $18000 | -$0.23 | -$0.24 | 4.17% |
| 2019-09-30 | 2019-11-12 | $18000 | -$0.26 | -$0.26 | 0.95% |
| 2019-06-30 | 2019-08-08 | $18000 | -$0.30 | -$0.54 | 44.78% |
| 2019-03-31 | 2019-05-09 | $6.78 million | -$0.31 | -$1.15 | 73.04% |
| 2018-12-31 | 2019-03-18 | $18000 | -$0.98 | -$1.14 | 14.04% |
| 2018-09-30 | 2018-11-08 | $18000 | -$1.18 | -$1.08 | -9.26% |
| 2018-06-30 | 2018-08-09 | $18000 | -$1.56 | -$1.96 | 20.41% |
| 2018-03-31 | 2018-05-10 | $18000 | -$1.80 | -$2.00 | 10% |
| 2017-12-31 | 2018-03-07 | $18000 | -$1.68 | -$1.92 | 12.5% |
| 2017-09-30 | 2017-11-07 | $18000 | -$2.16 | -$1.98 | -9.09% |
| 2017-06-30 | 2017-08-01 | $18000 | -$4.92 | -$3.33 | -47.75% |
| 2017-03-31 | 2017-05-04 | $18000 | -$4.56 | -$4.38 | -4.11% |
| 2016-12-31 | 2017-03-02 | $18000 | -$4.56 | -$4.26 | -7.04% |
| 2016-09-30 | 2016-11-01 | $204000 | -$4.44 | -$4.20 | -5.71% |
| 2016-06-30 | 2016-08-02 | $483000 | -$4.80 | -$4.46 | -7.53% |
| 2016-03-31 | 2016-05-02 | $489000 | -$4.80 | -$3.88 | -23.71% |
| 2015-12-31 | 2016-02-22 | $10.86 million | -$1.68 | -$2.48 | 32.26% |
| 2015-09-30 | 2015-11-05 | $1.87 million | -$0.25 | -$0.37 | 32.43% |
| 2015-06-30 | 2015-08-04 | $3.83 million | -$0.41 | -$0.28 | -46.43% |
| 2015-03-31 | 2015-05-07 | $4.2 million | -$0.29 | -$0.26 | -11.54% |
| 2014-12-31 | 2015-02-18 | $4.22 million | -$0.47 | -$0.21 | -123.81% |
| 2014-09-30 | 2014-11-05 | $1.08 million | -$0.23 | -$0.23 | 0% |
| 2014-06-30 | 2014-08-06 | $736000 | -$3.48 | -$2.26 | -53.98% |
| 2014-03-31 | 2014-05-08 | $1.63 million | -$3.60 | -$1.73 | -108.09% |
| 2013-12-31 | 2014-02-27 | $5.45 million | -$1.32 | -$1.51 | 12.58% |
| 2013-09-30 | 2013-11-13 | $6.12 million | -$0.60 | -$1.78 | 66.29% |
| 2013-06-30 | 2013-08-13 | $4.76 million | -$2.40 | -$1.68 | -42.86% |
| 2013-03-31 | 2013-05-14 | $3.24 million | -$2.40 | -$1.32 | -81.82% |
| 2012-12-31 | 2013-02-20 | $3.24 million | -$2.64 | -$0.86 | -206.98% |
| 2012-09-30 | 2012-11-19 | $2.81 million | -$0.12 | -$2.00 | 94% |
Regulus Therapeutics Inc (RGLS) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Regulus Therapeutics Inc (RGLS) Chart:
Regulus Therapeutics Inc (RGLS) News:
Below you will find a list of latest news for Regulus Therapeutics Inc (RGLS) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Regulus Therapeutics Inc (RGLS) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-21 | 1 | 0.5 | CALL | 1 | 27 | 280.14 | TRUE | 0.3 | 1.5 |
| 2025-03-21 | 2 | 0.1 | CALL | 0 | 510 | 174.62 | FALSE | 0 | 0 |
| 2025-03-21 | 3 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 4 | 0 | CALL | 0 | 0 | 536.53 | FALSE | 0 | 0 |
| 2025-03-21 | 1 | 0.25 | PUT | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 2 | 0 | PUT | 0 | 0 | 689.76 | TRUE | 0 | 0 |
| 2025-03-21 | 3 | 0 | PUT | 0 | 0 | 300.88 | TRUE | 0 | 0 |
| 2025-03-21 | 4 | 0 | PUT | 0 | 0 | 306.86 | TRUE | 0 | 0 |
| 2025-04-17 | 1 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-04-17 | 2 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 3 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 4 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 1 | 0.15 | PUT | 1 | 0 | 153.09 | FALSE | 0.15 | 0 |
| 2025-04-17 | 2 | 0 | PUT | 0 | 0 | 392.65 | TRUE | 0 | 0 |
| 2025-04-17 | 3 | 0 | PUT | 0 | 0 | 220.14 | TRUE | 0 | 0 |
| 2025-04-17 | 4 | 0 | PUT | 0 | 0 | 567.89 | TRUE | 0 | 0 |
| 2025-05-16 | 1 | 0.45 | CALL | 0 | 108 | 0 | TRUE | 0 | 0 |
| 2025-05-16 | 2 | 0.2 | CALL | 1 | 665 | 157.2 | FALSE | -0.04 | -0.17 |
| 2025-05-16 | 3 | 0.2 | CALL | 0 | 200 | 161.05 | FALSE | 0 | 0 |
| 2025-05-16 | 4 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-05-16 | 5 | 0.1 | CALL | 0 | 55 | 463.87 | FALSE | 0 | 0 |
| 2025-05-16 | 1 | 0.3 | PUT | 0 | 10 | 164.33 | FALSE | 0 | 0 |
| 2025-05-16 | 2 | 0 | PUT | 0 | 0 | 254.94 | TRUE | 0 | 0 |
| 2025-05-16 | 3 | 1.95 | PUT | 0 | 10 | 351.08 | TRUE | 0 | 0 |
| 2025-05-16 | 4 | 0 | PUT | 0 | 0 | 151.64 | TRUE | 0 | 0 |
| 2025-05-16 | 5 | 0 | PUT | 0 | 0 | 306.59 | TRUE | 0 | 0 |
| 2025-08-15 | 1 | 0.45 | CALL | 0 | 26 | 241.76 | TRUE | 0 | 0 |
| 2025-08-15 | 2 | 0.27 | CALL | 0 | 160 | 122.57 | FALSE | 0 | 0 |
| 2025-08-15 | 3 | 0 | CALL | 0 | 0 | 349.32 | FALSE | 0 | 0 |
| 2025-08-15 | 4 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-08-15 | 5 | 0.1 | CALL | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2025-08-15 | 1 | 0 | PUT | 0 | 0 | 203.38 | FALSE | 0 | 0 |
| 2025-08-15 | 2 | 0.89 | PUT | 0 | 2 | 166.39 | TRUE | 0 | 0 |
| 2025-08-15 | 3 | 1.95 | PUT | 0 | 45 | 234.89 | TRUE | 0 | 0 |
| 2025-08-15 | 4 | 0 | PUT | 0 | 0 | 231.28 | TRUE | 0 | 0 |
| 2025-08-15 | 5 | 0 | PUT | 0 | 0 | 250.27 | TRUE | 0 | 0 |
Latest RGLS Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 2:59 PM EST | 100 | $0.2518 |
| Jun 13, 2022 5:32 PM EST | 3 | $0.2469 |
Regulus Therapeutics Inc (RGLS) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120037968/0001209191-20-037968-index.htm |
| 2019-06-11 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1505512/000000000019009721/0000000000-19-009721-index.htm |
| 2020-01-27 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1505512/000000000020000672/0000000000-20-000672-index.htm |
| 2019-05-17 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1505512/000089914019000406/0000899140-19-000406-index.htm |
| 2020-01-03 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1505512/000089914020000007/0000899140-20-000007-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1505512/000092189520000575/0000921895-20-000575-index.htm |
| 2020-01-03 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1505512/000093583620000003/0000935836-20-000003-index.htm |
| 2019-05-15 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1505512/000107261319000192/0001072613-19-000192-index.htm |
| 2019-05-14 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1505512/000116998719000001/0001169987-19-000001-index.htm |
| 2019-03-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312519070800/0001193125-19-070800-index.htm |
| 2019-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312519077541/0001193125-19-077541-index.htm |
| 2019-04-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312519106523/0001193125-19-106523-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312519143173/0001193125-19-143173-index.htm |
| 2019-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312519147265/0001193125-19-147265-index.htm |
| 2019-05-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312519150546/0001193125-19-150546-index.htm |
| 2019-06-05 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1505512/000119312519166088/0001193125-19-166088-index.htm |
| 2019-06-12 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1505512/000119312519170897/0001193125-19-170897-index.htm |
| 2019-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312519171207/0001193125-19-171207-index.htm |
| 2019-06-17 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1505512/000119312519174907/0001193125-19-174907-index.htm |
| 2019-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312519180053/0001193125-19-180053-index.htm |
| 2019-07-01 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1505512/000119312519186518/0001193125-19-186518-index.htm |
| 2019-07-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312519202672/0001193125-19-202672-index.htm |
| 2019-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312519207108/0001193125-19-207108-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312519214057/0001193125-19-214057-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312519216898/0001193125-19-216898-index.htm |
| 2019-08-22 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1505512/000119312519226942/0001193125-19-226942-index.htm |
| 2019-09-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312519239961/0001193125-19-239961-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312519289956/0001193125-19-289956-index.htm |
| 2019-11-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312519298510/0001193125-19-298510-index.htm |
| 2019-12-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312519323073/0001193125-19-323073-index.htm |
| 2020-01-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312520001387/0001193125-20-001387-index.htm |
| 2020-01-22 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1505512/000119312520012118/0001193125-20-012118-index.htm |
| 2020-01-23 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1505512/000119312520012277/0001193125-20-012277-index.htm |
| 2020-01-27 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1505512/000119312520015459/0001193125-20-015459-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1505512/000119312520029094/0001193125-20-029094-index.htm |
| 2020-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312520050187/0001193125-20-050187-index.htm |
| 2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312520071579/0001193125-20-071579-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1505512/000119312520124163/0001193125-20-124163-index.htm |
| 2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1505512/000119312520124190/0001193125-20-124190-index.htm |
| 2020-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312520142829/0001193125-20-142829-index.htm |
| 2020-06-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312520174002/0001193125-20-174002-index.htm |
| 2020-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312520219184/0001193125-20-219184-index.htm |
| 2020-08-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312520236211/0001193125-20-236211-index.htm |
| 2020-10-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1505512/000119312520267795/0001193125-20-267795-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000119312520286871/0001193125-20-286871-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119023084/0001209191-19-023084-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119023087/0001209191-19-023087-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119023136/0001209191-19-023136-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028275/0001209191-19-028275-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028277/0001209191-19-028277-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028280/0001209191-19-028280-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028281/0001209191-19-028281-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028589/0001209191-19-028589-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028590/0001209191-19-028590-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028591/0001209191-19-028591-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028593/0001209191-19-028593-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028594/0001209191-19-028594-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028596/0001209191-19-028596-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028598/0001209191-19-028598-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028600/0001209191-19-028600-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028602/0001209191-19-028602-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028604/0001209191-19-028604-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028606/0001209191-19-028606-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028608/0001209191-19-028608-index.htm |
| 2019-05-10 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028710/0001209191-19-028710-index.htm |
| 2019-05-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119030503/0001209191-19-030503-index.htm |
| 2019-05-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119030506/0001209191-19-030506-index.htm |
| 2019-05-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119030512/0001209191-19-030512-index.htm |
| 2019-05-16 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119030569/0001209191-19-030569-index.htm |
| 2019-05-21 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119031763/0001209191-19-031763-index.htm |
| 2019-05-21 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119031764/0001209191-19-031764-index.htm |
| 2019-05-21 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119031766/0001209191-19-031766-index.htm |
| 2019-05-21 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119031767/0001209191-19-031767-index.htm |
| 2019-06-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119036106/0001209191-19-036106-index.htm |
| 2019-06-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119036107/0001209191-19-036107-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119040500/0001209191-19-040500-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119040502/0001209191-19-040502-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119040504/0001209191-19-040504-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119046312/0001209191-19-046312-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119046314/0001209191-19-046314-index.htm |
| 2019-09-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119047992/0001209191-19-047992-index.htm |
| 2019-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119047993/0001209191-19-047993-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119051910/0001209191-19-051910-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119051945/0001209191-19-051945-index.htm |
| 2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119053158/0001209191-19-053158-index.htm |
| 2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119053159/0001209191-19-053159-index.htm |
| 2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119053161/0001209191-19-053161-index.htm |
| 2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119053163/0001209191-19-053163-index.htm |
| 2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119053164/0001209191-19-053164-index.htm |
| 2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119053166/0001209191-19-053166-index.htm |
| 2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119053167/0001209191-19-053167-index.htm |
| 2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119053168/0001209191-19-053168-index.htm |
| 2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119053170/0001209191-19-053170-index.htm |
| 2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119053173/0001209191-19-053173-index.htm |
| 2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119053175/0001209191-19-053175-index.htm |
| 2019-11-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119056799/0001209191-19-056799-index.htm |
| 2019-11-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119056800/0001209191-19-056800-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119061855/0001209191-19-061855-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119061856/0001209191-19-061856-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119061857/0001209191-19-061857-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119061858/0001209191-19-061858-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119061963/0001209191-19-061963-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119061965/0001209191-19-061965-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119061966/0001209191-19-061966-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119061967/0001209191-19-061967-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119061968/0001209191-19-061968-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119061969/0001209191-19-061969-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119061971/0001209191-19-061971-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119061972/0001209191-19-061972-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119061975/0001209191-19-061975-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119061977/0001209191-19-061977-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119061978/0001209191-19-061978-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919119061979/0001209191-19-061979-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120000777/0001209191-20-000777-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120000785/0001209191-20-000785-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120004810/0001209191-20-004810-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120004811/0001209191-20-004811-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120004813/0001209191-20-004813-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120006429/0001209191-20-006429-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120006435/0001209191-20-006435-index.htm |
| 2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120010752/0001209191-20-010752-index.htm |
| 2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120010754/0001209191-20-010754-index.htm |
| 2020-05-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120030087/0001209191-20-030087-index.htm |
| 2020-05-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120030089/0001209191-20-030089-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120037948/0001209191-20-037948-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120037951/0001209191-20-037951-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120037953/0001209191-20-037953-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120037954/0001209191-20-037954-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120037957/0001209191-20-037957-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120037960/0001209191-20-037960-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120037962/0001209191-20-037962-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120037968/0001209191-20-037968-index.htm |
| 2020-08-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120044666/0001209191-20-044666-index.htm |
| 2020-08-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120044925/0001209191-20-044925-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120047031/0001209191-20-047031-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000120919120047033/0001209191-20-047033-index.htm |
| 2019-05-17 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1505512/000138713119003780/0001387131-19-003780-index.htm |
| 2019-12-31 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1505512/000138713119010005/0001387131-19-010005-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1505512/000138713120001707/0001387131-20-001707-index.htm |
| 2020-03-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1505512/000156459020013592/0001564590-20-013592-index.htm |
| 2019-05-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000156761919011605/0001567619-19-011605-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000156761920000438/0001567619-20-000438-index.htm |
| 2020-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000156761920009389/0001567619-20-009389-index.htm |
| 2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1505512/000156761920009390/0001567619-20-009390-index.htm |
| 2019-03-18 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1505512/000162828019003037/0001628280-19-003037-index.htm |
| 2019-04-29 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1505512/000162828019004952/0001628280-19-004952-index.htm |
| 2019-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1505512/000162828019006483/0001628280-19-006483-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1505512/000162828019010478/0001628280-19-010478-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1505512/000162828019013991/0001628280-19-013991-index.htm |
| 2020-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1505512/000162828020003483/0001628280-20-003483-index.htm |
| 2020-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1505512/000162828020007809/0001628280-20-007809-index.htm |
| 2020-08-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1505512/000162828020012643/0001628280-20-012643-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1505512/000162828020015789/0001628280-20-015789-index.htm |
| 2019-06-14 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1505512/999999999519001357/9999999995-19-001357-index.htm |
| 2020-01-29 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1505512/999999999520000189/9999999995-20-000189-index.htm |
| 2019-04-16 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1505512/999999999719002961/9999999997-19-002961-index.htm |
| 2020-03-03 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1505512/999999999720001114/9999999997-20-001114-index.htm |
| 2020-05-19 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1505512/999999999720002980/9999999997-20-002980-index.htm |
Regulus Therapeutics Inc (RGLS) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Regulus Therapeutics Inc (RGLS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 643%Institutional Ownership: 3100%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-05-07 | STELIOS PAPADOPOULOS | Director | Buy | 370,370.00 | 1.08 | 399,999.60 | 1,189,872.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028275/0001209191-19-028275-index.htm |
| 2019-05-07 | WILLIAM H RASTETTER | Director | Buy | 92,889.00 | 1.08 | 100,320.12 | 154,223.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028277/0001209191-19-028277-index.htm |
| 2019-05-07 | Ali Behbahani | 10% Share Holder | Buy | 1,136,704.00 | 1.08 | 1,227,640.32 | 2,052,454.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028593/0001209191-19-028593-index.htm |
| 2019-05-07 | Anthony A. Jr. Florence | 10% Share Holder | Buy | 1,136,704.00 | 1.08 | 1,227,640.32 | 2,052,454.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028596/0001209191-19-028596-index.htm |
| 2019-05-07 | Carmen Chang | 10% Share Holder | Buy | 1,136,704.00 | 1.08 | 1,227,640.32 | 2,052,454.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028594/0001209191-19-028594-index.htm |
| 2019-05-07 | DAVID M MOTT | 10% Share Holder | Buy | 1,136,704.00 | 1.08 | 1,227,640.32 | 2,052,454.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028602/0001209191-19-028602-index.htm |
| 2019-05-07 | FOREST BASKETT | 10% Share Holder | Buy | 1,136,704.00 | 1.08 | 1,227,640.32 | 2,052,454.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028591/0001209191-19-028591-index.htm |
| 2019-05-07 | Growth Equity Opportunities V, LLC | 10% Share Holder | Buy | 1,136,704.00 | 1.08 | 1,227,640.32 | 2,052,454.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028589/0001209191-19-028589-index.htm |
| 2019-05-07 | JOSHUA MAKOWER | 10% Share Holder | Buy | 1,136,704.00 | 1.08 | 1,227,640.32 | 2,052,454.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028600/0001209191-19-028600-index.htm |
| 2019-05-07 | Mohamad Makhzoumi | 10% Share Holder | Buy | 1,136,704.00 | 1.08 | 1,227,640.32 | 2,052,454.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028598/0001209191-19-028598-index.htm |
| 2019-05-07 | Paul Edward Walker | Director | Buy | 1,136,704.00 | 1.08 | 1,227,640.32 | 2,052,454.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028608/0001209191-19-028608-index.htm |
| 2019-05-07 | PETER J BARRIS | 10% Share Holder | Buy | 1,136,704.00 | 1.08 | 1,227,640.32 | 2,052,454.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028590/0001209191-19-028590-index.htm |
| 2019-05-07 | Peter W. Sonsini | 10% Share Holder | Buy | 1,136,704.00 | 1.08 | 1,227,640.32 | 2,052,454.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028606/0001209191-19-028606-index.htm |
| 2019-05-07 | SCOTT D SANDELL | 10% Share Holder | Buy | 1,136,704.00 | 1.08 | 1,227,640.32 | 2,052,454.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028604/0001209191-19-028604-index.htm |
| 2020-08-14 | Joseph P Hagan | President and CEO | Sell | 4,245.00 | 0.60 | 2,567.80 | 222,088.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919120047033/0001209191-20-047033-index.htm |
| 2020-05-15 | Joseph P Hagan | President and CEO | Sell | 4,426.00 | 0.63 | 2,773.77 | 226,333.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919120030089/0001209191-20-030089-index.htm |
| 2020-02-18 | Joseph P Hagan | President and CEO | Sell | 4,324.00 | 0.83 | 3,590.65 | 230,759.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919120010754/0001209191-20-010754-index.htm |
| 2020-01-02 | Joseph P Hagan | President and CEO | Sell | 8,345.00 | 0.97 | 8,067.11 | 235,083.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919120000785/0001209191-20-000785-index.htm |
| 2019-11-14 | Joseph P Hagan | President and CEO | Sell | 5,838.00 | 0.64 | 3,736.32 | 243,428.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119056799/0001209191-19-056799-index.htm |
| 2019-10-01 | Joseph P Hagan | President and CEO | Sell | 8,743.00 | 0.68 | 5,968.85 | 249,266.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119051910/0001209191-19-051910-index.htm |
| 2019-08-15 | Joseph P Hagan | President and CEO | Sell | 4,375.00 | 0.55 | 2,408.88 | 258,009.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119046314/0001209191-19-046314-index.htm |
| 2019-07-01 | Joseph P Hagan | President and CEO | Sell | 5,783.00 | 1.31 | 7,584.40 | 262,384.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119040504/0001209191-19-040504-index.htm |
| 2020-08-14 | Christopher Ray Aker | Sr. VP & General Counsel | Sell | 872.00 | 0.61 | 527.56 | 26,638.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919120047031/0001209191-20-047031-index.htm |
| 2019-05-16 | Joseph P Hagan | President and CEO | Sell | 39,352.00 | 1.22 | 47,966.15 | 268,167.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119030512/0001209191-19-030512-index.htm |
| 2020-05-15 | Christopher Ray Aker | Sr. VP & General Counsel | Sell | 909.00 | 0.63 | 569.76 | 27,510.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919120030087/0001209191-20-030087-index.htm |
| 2020-02-18 | Christopher Ray Aker | Sr. VP & General Counsel | Sell | 888.00 | 0.83 | 737.48 | 28,419.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919120010752/0001209191-20-010752-index.htm |
| 2020-01-02 | Christopher Ray Aker | Sr. VP & General Counsel | Sell | 2,239.00 | 0.97 | 2,164.44 | 29,307.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919120000777/0001209191-20-000777-index.htm |
| 2019-05-14 | Joseph P Hagan | President and CEO | Buy | 188,385.00 | 307,519.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119030512/0001209191-19-030512-index.htm | ||
| 2019-04-01 | Joseph P Hagan | President and CEO | Sell | 5,842.00 | 0.98 | 5,731.00 | 31,348.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119023136/0001209191-19-023136-index.htm |
| 2019-11-14 | Christopher Ray Aker | Sr. VP & General Counsel | Sell | 833.00 | 0.64 | 533.12 | 31,546.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119056800/0001209191-19-056800-index.htm |
| 2019-10-01 | Christopher Ray Aker | Sr. VP & General Counsel | Sell | 2,346.00 | 0.68 | 1,601.61 | 32,379.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119051945/0001209191-19-051945-index.htm |
| 2019-08-15 | Christopher Ray Aker | Sr. VP & General Counsel | Sell | 899.00 | 0.55 | 494.99 | 34,725.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119046312/0001209191-19-046312-index.htm |
| 2019-07-01 | Christopher Ray Aker | Sr. VP & General Counsel | Sell | 2,225.00 | 1.31 | 2,918.09 | 35,624.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119040502/0001209191-19-040502-index.htm |
| 2019-05-07 | Pascale Witz | Director | Buy | 29,630.00 | 1.08 | 32,000.40 | 37,849.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028280/0001209191-19-028280-index.htm |
| 2019-05-15 | Christopher Ray Aker | Sr. VP & General Counsel | Sell | 6,950.00 | 1.41 | 9,796.03 | 59,309.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119030503/0001209191-19-030503-index.htm |
| 2019-04-01 | Christopher Ray Aker | Sr. VP & General Counsel | Sell | 2,710.00 | 0.98 | 2,659.05 | 6,287.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119023084/0001209191-19-023084-index.htm |
| 2019-05-07 | Joseph P Hagan | President and CEO | Buy | 33,194.00 | 1.08 | 35,849.52 | 64,542.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119028281/0001209191-19-028281-index.htm |
| 2019-05-14 | Christopher Ray Aker | Sr. VP & General Counsel | Buy | 38,512.00 | 66,259.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119030503/0001209191-19-030503-index.htm | ||
| 2019-07-01 | Daniel R. Chevallard | Chief Financial Officer | Sell | 2,669.00 | 1.31 | 3,500.39 | 77,870.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119040500/0001209191-19-040500-index.htm |
| 2019-05-15 | Daniel R. Chevallard | Chief Financial Officer | Sell | 10,000.00 | 1.41 | 14,089.00 | 80,539.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119030506/0001209191-19-030506-index.htm |
| 2019-05-14 | Daniel R. Chevallard | Chief Financial Officer | Buy | 55,414.00 | 90,539.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119030506/0001209191-19-030506-index.htm | ||
| 2019-04-01 | Daniel R. Chevallard | Chief Financial Officer | Sell | 3,253.00 | 0.98 | 3,192.49 | 9,372.00 | https://www.sec.gov/Archives/edgar/data/1505512/000120919119023087/0001209191-19-023087-index.htm |